
    
      Anti-HER2 single domain antibody will be labeled with 99mTc and 188Re to prepare 99mTc-NM-02
      and 188Re-NM-02, respectively. 99mTc-NM-02 is used as a diagnostic agent for SPECT/CT imaging
      of HER2 expression, and 188Re-NM-02 is used as a therapeutic drug for radionuclide therapy of
      HER2-postive Breast Cancer.
    
  